Juvenile angiofibroma: etiology, diagnosis, treatment
DOI:
https://doi.org/10.12775/JEHS.2020.10.09.029Keywords
computed tomography, digital subtraction angiography, embolization, juvenile nasopharyngeal angiofibroma, magnetic resonance imagingAbstract
Introduction and purpose: Juvenile angiofibroma is a rare neoplasm of the nasopharynx. It occurs almost exclusively in boys during adolescence. It is a richly vascularized neoplasm which, despite its benign histopathological character, tends to invasive growth and recurrence. The aim of the study is to review current data on juvenile angiofibroma.
Brief description of the state of knowledge: Juvenile angiofibroma primary develops on the posterolateral wall of the nasal cavity, growing out of the wedge-palatal opening. Common symptoms resulting from its location, there are bleeding and nasal obstruction. Tumor diagnosis is based in imaging tests - CT and MRI, in which juvenile angiofibroma exhibits some distinctive features. CT and MR examinations demonstrate the typical the location and route of spread of juvenile angiofibroma and allow to assess the extent of the tumor. The angiography allows for confirmation diagnosis of a vascular tumor and enables preoperative embolization. Surgical treatment is the most common therapeutic procedure and irradiating the tumor, depending on its location. Due to the vascularnature of the tumor, the basic preoperative procedure is tumor vessel embolization, which allows reducing blood loss during surgery.
Conclusions: Juvenile angiofibroma shows some characteristic features - it occurs at a similar age, in one sex and in one localization in the organism. Due to the invasive tumor growth, the risk of bone destruction and relapse, the role of imaging tests is important, allowing the diagnosis of a tumor at an early stage of its development.
References
Lopez F, Triantafyllou A, Snyderman C, et al. Nasal juvenile angiofibroma: Current perspectives with emphasis on management. Head & Neck. 2017;39(5):1033-1045.
Łukomski M., Danilewicz M., Pajor A. Naczyniakowłókniak młodzieńczy u dorosłych. [Juvenile angiofibroma in adults]. Otolaryngologia Polska. [Polish otolaryngology]. 2008;LXII(1):20-26. Polish.
Lund VJ, Stammberger H, Fokkens WJ, et al. European position paper on the anatomical terminology of the internal nose and paranasal sinuses. Rhinol Suppl. 2014; 24: 1– 34.
Pucher B., Jończyk-Potoczna K., Grzegorowski M., Ryglewicz M., Szydłowski J. Ocena wyników leczenia chirurgicznego chorych z naczyniakowłókniakiem młodzieńczym. [Assessent of the surgical treatment in patients with juvenile angiofibroma]. Otolaryngologia. [Otolaryngology]. 2015;14(1):15-19. Polish.
Szymańska A., Jargiełło T., Drelich-Zbroja A., Szymański M., Szczerbo-Trojanowska M. Naczyniakowłókniak młodzieńczy: znaczenie diagnostyki angiograficznej i przedoperacyjnej embolizacji w postępowaniu leczniczym. [Juvenile angiofibroma: the role of diagnostic angiography and preoperative embolization in treatment]. Postępy Nauk Medycznych. [Advances in Medical Sciences]. 2012;XXV(5):459-463. Polish.
Sawicki P., Kaźmierczak H. Trudności lecznicze w naczyniakowłókniaku młodzieńczym. [The difficulties in treating juvenile angiofibroma]. Acta Angiol. 2010;16(4):181-189. Polish.
Liu Z, Wang J, Wang H, et al. Hormonal receptors and vascular endothelial growth factor in juvenile nasopharyngeal angiofibroma: immunohistochemical and tissue microarray analysis. Acta Otolaryngol 2015;135:51–57.
Riggs S, Orlandi RR. Juvenile nasopharyngeal angiofibroma recurrence associated with exogenous testosterone therapy. Head Neck 2010;32:812–815.
Gatalica Z. Immunohistochemical analysis of steroid hormone receptors in nasopharyngeal angiofibromas. Cancer Lett 1998;127:89–93.
Silveira SM, Custódio Domingues MA, Butugan O, Brentani MM, Rogatto SR. Tumor microenvironmental genomic alterations in juvenile nasopharyngeal angiofibroma. Head Neck 2012;34:485–492.
Schick B, Veldung B, Wemmert S, et al. p53 and Her‐2/neu in juvenile angiofibromas. Oncol Rep 2005;13:453–457.
Ponti G, Losi L, Pellacani G, et al. Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis‐associated juvenile nasopharyngeal angiofibromas (JNA). Appl Immunohistochem Mol Morphol 2008;16:173–178.
Renkonen S, Heikkilä P, Haglund C, Mäkitie AA, Hagström J. Tenascin‐C, GLUT‐1, and syndecan‐2 expression in juvenile nasopharyngeal angiofibroma: correlations to vessel density and tumor stage. Head Neck 2013;35:1036–1042.
Mishra A, Sachadeva M, Jain A, Shukla NM, Pandey A. Human papilloma virus in juvenile nasopharyngeal angiofibroma: possible recent trend. Am J Otolaryngol 2016;37:317–322.
Leong SC. A systematic review of surgical outcomes for advanced juvenile nasopharyngeal angiofibroma with intracranial involvement. Laryngoscope 2013; 123: 1125– 1131.
Gołąbek W., Szymańska A., Szymański M., Czekajska-Chehab E., Jargiełło T. Juvenile nasopharyngeal angiofibroma with intracranial extension - diagnosis and treatment. Otolaryngologia Polska. 2020;7 (2): 1-7.
Szymańska A, Szymański M, Czekajska-Chehab E, Szczerbo-Trojanowska M. Invasive growth patterns of juvenile nasopharyngeal angiofibroma:radiological imaging and clinical implications. Acta Radiologica. 2014;55(6):725-731.
Bertazzoni G., Schreiber A., Ferrari M., Nicolai P., Contemporary management of juvenile angiofibroma, Current Opinion in Otolaryngology & Head and Neck Surgery. 2019;27(1): 47-53.
Nicolai P, Schreiber A, Bolzoni Villaret A. Juvenile angiofibroma: evolution of management. Int J Pediatr. 2012; 1-11.
Szymańska A, Szymański M, Czekajska-Chehab E, Szczerbo-Trojanowska M. Two types of lateral extension in juvenile nasopharyngeal angiofibroma: diagnostic and therapeutic management. European Archives of Oto-Rhino-Laryngology. 2015;272:159-166.
Lutz J, Holtmannspötter M, Flatz W, et al. Preoperative embolization to improve the surgical management and outcome of juvenile nasopharyngeal angiofibroma (JNA) in a single center: 10‐year experience. Clin Neuroradiol. 2016; 26: 405– 413.
Safadi A, Schreiber A, Fliss DM, Nicolai P. Juvenile Angiofibroma: Current Management Strategies. Journal of Neurological Surgery Part B: Skull Base. 2018;79(1): 21-30.
Hackman T, Snyderman CH, Carrau R, Vescan A, Kassam A. Juvenile nasopharyngeal angiofibroma: the expanded endonasal approach. Am J Rhinol Allergy 2009; 23: 95– 99.
Tosun F, Onerci M, Durmaz A, Ugurel S. Spontaneous involution of nasopharyngeal angiofibroma. J Craniofac Surg.2008; 19: 1686– 1689.
Deschler DG, Kaplan MJ, Boles R.: Treatment of large juvenile nasopharyngeal angiofibroma. Otolaryngol Head Neck Surg. 1992, 106, 278-284.
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 789
Number of citations: 0